Isra Presisi Indonesia Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Isra Presisi Indonesia Tbk. trades at Rp25 (market cap 100.51B, 7.29M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 164.65B, 187.4K 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is the larger of the two by market cap, and Isra Presisi Indonesia Tbk. is more actively traded (7.29M versus 187.4K). Which is the better fit depends on your goals.
| ISAP | OBAT | |
|---|---|---|
Market Cap | 100.51B | 164.65B |
Volume | 7.29M | 187.4K |
Lot | 72.93K | 1.87K |
Turnover | 176.33M | 44.35M |
Average Price | 24.18 | 236.67 |
Value | 176.33M | 44.35M |
Indicative Equilibrium Price | 25 | 242 |
Indicative Equilibrium Volume | 1.51K | 500 |
Trailing returns across standard periods
Latest headlines on both assets
PT Isra Presisi Indonesia Tbk ("The Company") was established on October 22, 2011 based on Notary Deed No. 47 of Evi Nursamsiyati, S.H. The Company started its commercial operations in2011.
Read more on ISAP →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →